Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Citi
UBS
Dow
Chubb
Harvard Business School
QuintilesIMS
US Army

Generated: July 18, 2018

DrugPatentWatch Database Preview

Alcaftadine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for alcaftadine and what is the scope of alcaftadine patent protection?

Alcaftadine
is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Alcaftadine has forty patent family members in twenty-eight countries.

There are six drug master file entries for alcaftadine. Three suppliers are listed for this compound.
Pharmacology for alcaftadine
Synonyms for alcaftadine
(Unlabelled)Alcaftadine-13C-D3
11-(1-methyl-4-piperidylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,3-b][3]benzazepine-3-carbaldehyde
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine-3-carbaldehyde
147084-10-4
2-(1-methylpiperidin-4-ylidene)-4,7-diazatricyclo[8.4.0.0;{3,7}]tetradeca-1(14),3,5,10,12-pentaene-6-carbaldehyde
2-(1-METHYLPIPERIDIN-4-YLIDENE)-4,7-DIAZATRICYCLO[8.4.0.0(3),?]TETRADECA-1(10),3,5,11,13-PENTAENE-6-CARBALDEHYDE
5H-Imidazo(2,1-b)(3)benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4- piperidinylidene)-
5H-Imidazo[2,1-b][3]benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-
5H-Imidazo[2,1-b][3]benzazepine-3-carboxaldehyde,6,11-dihydro-11-(1-methyl-4-piperidinylidene)-
7Z8O94ECSX
AC-28019
AKOS025402002
alcaftadina
Alcaftadine (JAN/USAN/INN)
Alcaftadine [USAN:INN]
Alcaftadine, >=98% (HPLC)
alcaftadinum
AM84429
AN-022
AOB6728
API0007478
BCP0726000082
BCP9000269
CHEBI:71023
CHEMBL1201747
CS-2842
D06552
D0O7JW
DB06766
DTXSID80598455
FT-0661472
GTPL7587
HY-17039
Lastacaft
Lastacaft (TN)
MolPort-023-219-144
PL005675
R 89674
R-89674
R89674
s4625
SCHEMBL1602418
UNII-7Z8O94ECSX
Vilasta
X6443
ZINC11726211

US Patents and Regulatory Information for alcaftadine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan LASTACAFT alcaftadine SOLUTION/DROPS;OPHTHALMIC 022134-001 Jul 28, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
McKesson
Mallinckrodt
Chubb
Queensland Health
Moodys
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.